The U.S. Food and Drug Administration (FDA) declined to approve a new drug application for a second nasal spray version of the opioid overdose antidote naloxone, Medscape reports. The FDA approved a nasal spray version of naloxone last month.
The Food and Drug Administration on Tuesday ordered tobacco company R.J. Reynolds to stop selling four cigarette products. It is the first time the agency has ordered a major tobacco company to stop selling products, according to NPR.
The Food and Drug Administration issued a rule this week that allows the agency to destroy poor-quality or fake drugs valued at $2,500 or less that are refused admission into the United States. Until now, only counterfeit or poor quality food or medical devices could be destroyed.
An advisory panel to the Food and Drug Administration (FDA) has voted in favor of approving a new opioid painkiller made by Collegium Pharmaceuticals. The panel’s unanimous vote was contrary to a recommendation by FDA staff, according to Reuters.
The Food and Drug Administration’s decision last month to approve the opioid painkiller OxyContin for children as young as 11 has been welcomed by some pediatricians and pain specialists, The Washington Post reports. Some critics, however, say the decision could lead to increased abuse of the drug.
New regulations for e-cigarettes are likely to have a large impact on the industry, experts say. The rules could force many small e-cigarette businesses to close, while benefitting large tobacco companies.